Man among first in US to get 'bionic eye' (Update)

April 23, 2014 by Mike Householder
In this April 16, 2014 image from video Roger Pontz wears special glasses that house a small video camera and transmitter at the University of Michigan Kellogg Eye Center on April 16, 2014, in Ann Arbor, Mich. The glasses are part of a system developed by a California company that wirelessly transmits images from the camera, converted into a series of electrical pulses, to an array of electrodes on the surface of Pontz' retna. The pulses stimulate the retina's remaining healthy cells, causing them to relay the data to the optic nerve. The visual information then moves to the brain, where it is translated into patterns of light that can take the shape of an object's outline, allowing the patient to regain some visual function. (AP Photo, Mike Householder)

A degenerative eye disease slowly robbed Roger Pontz of his vision. Diagnosed with retinitis pigmentosa as a teenager, Pontz has been almost completely blind for years. Now, thanks to a high-tech procedure that involved the surgical implantation of a "bionic eye," he's regained enough of his eyesight to catch small glimpses of his wife, grandson and cat.

"It's awesome. It's exciting—seeing something new every day," Pontz said during a recent appointment at the University of Michigan Kellogg Eye Center. The 55-year-old former competitive weightlifter and factory worker is one of four people in the U.S. to receive an artificial retina since the Food and Drug Administration signed off on its use last year.

The facility in Ann Arbor has been the site of all four such since FDA approval. A fifth is scheduled for next month.

Retinitis pigmentosa is an inherited disease that causes slow but progressive vision loss due to a gradual loss of the light-sensitive retinal cells called rods and cones. Patients experience loss of side vision and night vision, then central vision, which can result in near blindness.

Not all of the 100,000 or so people in the U.S. with retinitis pigmentosa can benefit from the . An estimated 10,000 have vision low enough, said Dr. Brian Mech, an executive with Second Sight Medical Products Inc., the Sylmar, Calif.-based company that makes the device. Of those, about 7,500 are eligible for the surgery.

The artificial implant in Pontz's left eye is part of a system developed by Second Sight that includes a small video camera and transmitter housed in a pair of glasses.

Images from the camera are converted into a series of electrical pulses that are transmitted wirelessly to an array of electrodes on the surface of the retina. The pulses stimulate the retina's remaining healthy cells, causing them to relay the signal to the optic nerve.

The visual information then moves to the brain, where it is translated into patterns of light that can be recognized and interpreted, allowing the patient to regain some visual function.

In this April 16, 2014 image from video Dr. Thiran Jayasundera, left, looks at Roger Pontz's left eye as Pontz's wife, Terri Pontz, right, looks on at the University of Michigan Kellogg Eye Center on April 16, 2014, in Ann Arbor, Mich. The artificial implant that currently resides in Pontz's left eye is called the Argus II, and is part of the system developed by a California company that includes a small video camera and transmitter housed in a pair of glasses. Images from the camera are converted into a series of electrical pulses that are transmitted wirelessly to an array of electrodes on the surface of the retina. (AP Photo, Mike Householder)

When wearing the glasses, which Pontz refers to as his "eyes," he can identify and grab his cat and figure out that a flash of light is his grandson hightailing it to the kitchen.

The visual improvement is sometimes startling for Pontz and his wife, Terri, who is just as amazed at her husband's progress as he is.

"I said something I never thought I'd say: 'Stop staring at me while I'm eating,'" Terri Pontz said.

She drives her husband the nearly 200 miles (320 kilometers) to Ann Arbor for check-ups and visits with occupational therapist Ashley Howson, who helps Roger Pontz reawaken his visual memory and learn techniques needed to make the most of his new vision.

At the recent visit, Howson handed Pontz white and black plates, instructed him to move them back and forth in front of light and dark backgrounds and asked that he determine their color.

Back home, Terri Pontz helps her husband practice the techniques he learns in Ann Arbor.

For them, the long hours on the road and the homework assignments are a blessing.

In this April 16, 2014 image from video Dr. Naheed Khan, right, works with Roger Pontz, left, on an exercise to test how well he sees shapes on a computer screen at the University of Michigan Kellogg Eye Center, April 16, 2014, in Ann Arbor, Mich. Pontz suffers from a degenerative eye disease called retinitis pigmentosa and is the second patient in the U.S. to surgically receive a "bionic eye" since the U.S. Food and Drug Administration signed off on its use last year. (AP Photo, Mike Householder)

"What's it worth to see again? It's worth everything," Terri Pontz said.

The procedure has been performed several-dozen times over the past few years in Europe, and the expectation is that it will find similar success in the U.S., where the University of Michigan is one of 12 centers accepting consultations for .

Candidates for the retinal prosthesis must be 25 or older with end-stage that has progressed to the point of having "bare light" or no light perception in both eyes.

Dr. Thiran Jayasundera, one of two physicians who performed the 4.5-hour surgery on Roger Pontz, is scheduled to discuss his experiences with the retinal prosthesis process during a meeting of the American Society of Cataract and Refractive Surgery on Friday in Boston. He calls it a "game-changer."

Pontz agrees: "I can walk through the house with ease. If that's all I get out of this, it'd be great."

Explore further: Eye implants make vision-restoring progress

Related Stories

Eye implants make vision-restoring progress

July 18, 2012
(Medical Xpress) -- "I was blind once but now I can see.” The words are no longer the sole property of religious testimony and literature. Medical progress is being made in the restoration of vision as evidenced by Second ...

New device offers hope to people blinded due to incurable eye disorders

November 17, 2013
Research presented at the 117th Annual Meeting of the American Academy of Ophthalmology shows promising data about a device that helps people who have lost their vision due to a blinding genetic disease to recognize common ...

Researcher advances retinal implant that could restore sight for the blind

November 15, 2013
People who went blind as a result of certain diseases or injuries may have renewed hope of seeing again thanks to a retinal implant developed with the help of FIU's W. Kinzy Jones, a professor and researcher in the College ...

Bionic eye gives hope to the blind

February 5, 2013
After years of research, the first bionic eye has seen the light of day in the United States, giving hope to the blind around the world.

Australians implant 'world first' bionic eye

August 30, 2012
Australian scientists said Thursday they had successfully implanted a "world first" bionic eye prototype, describing it as a major breakthrough for the visually impaired.

Retinal implants with wireless microchip restore functional vision in retinitis pigmentosa patients, research finds

February 20, 2013
(Medical Xpress)—Retina Implant AG, the leading developer of subretinal implants for patients blinded by retinitis pigmentosa (RP), announced results from part of its multicentre study were published today in the peer-reviewed ...

Recommended for you

Study advances gene therapy for glaucoma

January 16, 2018
While testing genes to treat glaucoma by reducing pressure inside the eye, University of Wisconsin-Madison scientists stumbled onto a problem: They had trouble getting efficient gene delivery to the cells that act like drains ...

New study offers added hope for patients awaiting corneal transplants

January 9, 2018
New national research led by Jonathan Lass of Case Western Reserve University School of Medicine has found that corneal donor tissue can be safely stored for 11 days before transplantation surgery to correct eye problems ...

Diabetic blindness caused and reversed "trapped" immune cells in rodent retinas

January 3, 2018
Johns Hopkins researchers have discovered a cell signaling pathway in mice that triggers vision loss in patients with diabetic retinopathy and retinal vein occlusion – diseases characterized by the closure of blood vessels ...

Ophthalmologists increasingly dissatisfied with electronic health records

December 29, 2017
Ophthalmologists' use of electronic health records (EHR) systems for storing and accessing patients' medical histories more than doubled between 2006 and 2016, while their perceptions of financial and clinical productivity ...

Higher omega-3 fatty acid intake tied to lower glaucoma risk

December 26, 2017
(HealthDay)—Increased daily intake of ω-3 fatty acids is associated with lower odds of glaucoma, but higher levels of total polyunsaturated fatty acid (PUFA) intake are associated with higher odds of developing glaucoma, ...

Protein analysis allows for treatment of eye-disease symptoms with existing drugs

December 21, 2017
Demonstrating the potential of precision health, a team led by a researcher at the Stanford University School of Medicine has matched existing drugs to errant proteins expressed by patients with a rare eye disease.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

TheGhostofOtto1923
1 / 5 (1) Apr 23, 2014
Well thats a coincidence - Lee Majors (born Harvey Lee Yeary on April 23, 1939)

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.